Insider Trading activities of Ultragenyx Pharmaceutical Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ultragenyx Pharmaceutical Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ultragenyx Pharmaceutical Inc. since year 2005. Table 2 shows the detailed insider transactions of Ultragenyx Pharmaceutical Inc. since 2005. The reporting company's ticker symbol is RARE. The reporting company's CIK number is 1515673.
The total value of stock buying since 2005 is $4,406,100.
The total value of stock sales since 2005 is $51,437,912.
The total value of stock option exercises since 2005 is $1,041,934.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Ultragenyx Pharmaceutical Inc. (RARE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-08 7,500 $395,100 0 $0 0 $0
2017-05 0 $0 480 $27,580 0 $0
2017-03 0 $0 14,500 $1,297,020 12,000 $9,780
2017-02 0 $0 36,000 $2,885,040 36,000 $29,340
2016-12 0 $0 0 $0 6,500 $5,265
2016-11 0 $0 46,000 $3,527,452 26,000 $61,560
2016-10 0 $0 32,000 $2,007,240 12,000 $9,780
2016-08 0 $0 20,000 $1,355,100 0 $0
2016-07 0 $0 20,649 $1,053,689 0 $0
2016-06 0 $0 3,250 $176,020 0 $0
2016-05 0 $0 20,650 $1,257,700 0 $0
2016-04 0 $0 20,649 $1,451,573 0 $0
2016-03 0 $0 650 $39,942 0 $0
2016-01 0 $0 585 $42,605 1,000 $21,000
2015-12 0 $0 33,998 $3,734,650 13,500 $41,280
2015-11 0 $0 20,498 $2,009,648 0 $0
2015-10 0 $0 20,649 $2,053,895 0 $0
2015-09 0 $0 498 $54,535 0 $0
2015-08 0 $0 20,354 $2,249,393 10,000 $558,800
2015-07 0 $0 14,896 $1,862,869 0 $0
2015-06 0 $0 8,834 $820,825 1,500 $31,500
2015-05 0 $0 7,334 $557,901 1,000 $815
2015-04 0 $0 7,333 $440,840 0 $0
2015-03 0 $0 7,333 $433,447 8,819 $185,199
2015-02 0 $0 7,333 $398,305 0 $0
2015-01 0 $0 7,333 $376,638 0 $0
2014-12 0 $0 13,333 $566,217 0 $0
2014-11 0 $0 7,333 $315,766 0 $0
2014-10 0 $0 7,333 $361,595 29,108 $87,615
2014-09 0 $0 27,333 $1,484,915 0 $0
2014-08 0 $0 4,000 $215,880 0 $0
2014-07 0 $0 488,820 $18,379,632 0 $0
2014-01 191,000 $4,011,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Ultragenyx Pharmaceutical Inc. insiders (RARE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-08-28 Kakkis Emil D (President & CEO) Buy 7,500 52.68 395,100
2017-05-26 Huizenga Theodore Alan (VP, Controller and PAO) Sale 480 57.46 27,580
2017-03-09 Huizenga Theodore Alan (Controller and PAO) Sale 2,500 86.34 215,844
2017-03-02 Sharp Shalini (CFO & Executive Vice President) Sale 12,000 90.10 1,081,176
2017-03-02 Sharp Shalini (CFO & Executive Vice President) Option Ex 12,000 .81 9,780
2017-02-27 Sharp Shalini (CFO & Executive Vice President) Sale 24,000 80.14 1,923,360
2017-02-27 Sharp Shalini (CFO & Executive Vice President) Option Ex 24,000 .81 19,560
2016-12-23 Sharp Shalini (CFO & Executive Vice President) Option Ex 6,500 .81 5,265
2016-11-16 Huizenga Theodore Alan (Controller and PAO) Sale 2,000 79.73 159,460
2016-11-16 Huizenga Theodore Alan (Controller and PAO) Option Ex 2,000 21.00 42,000
2016-11-15 Kakkis Emil D (President & CEO) Sale 20,000 81.39 1,627,800
2016-11-09 Sharp Shalini (CFO & Executive Vice President) Sale 24,000 72.51 1,740,192
2016-11-09 Sharp Shalini (CFO & Executive Vice President) Option Ex 24,000 .81 19,560
2016-10-19 Sharp Shalini (CFO & Senior Vice President) Sale 12,000 61.34 736,140
2016-10-19 Sharp Shalini (CFO & Senior Vice President) Option Ex 12,000 .81 9,780
2016-10-14 Kakkis Emil D (President & CEO) Sale 20,000 63.55 1,271,100
2016-08-15 Kakkis Emil D (President & CEO) Sale 20,000 67.75 1,355,100
2016-07-21 Agarwal Sunil (Chief Medical Officer) Sale 649 52.68 34,189
2016-07-15 Kakkis Emil D (President & CEO) Sale 20,000 50.98 1,019,500
2016-06-20 Agarwal Sunil (Chief Medical Officer) Sale 1,950 54.16 105,612
2016-05-24 Agarwal Sunil (Chief Medical Officer) Sale 650 66.00 42,900
2016-05-16 Kakkis Emil D (President & CEO) Sale 20,000 60.74 1,214,800
2016-04-20 Agarwal Sunil (Chief Medical Officer) Sale 649 70.53 45,773
2016-04-15 Kakkis Emil D (President & CEO) Sale 20,000 70.29 1,405,800
2016-03-22 Agarwal Sunil (Chief Medical Officer) Sale 650 61.45 39,942
2016-01-20 Agarwal Sunil (Chief Medical Officer) Sale 585 72.83 42,605
2016-01-14 Huizenga Theodore Alan (Controller and PAO) Option Ex 1,000 21.00 21,000
2015-12-31 Kakkis Emil D (President & CEO) Sale 5,498 113.78 625,578
2015-12-30 Kakkis Emil D (President & CEO) Sale 14,502 114.94 1,666,932
2015-12-22 Agarwal Sunil (Chief Medical Officer) Sale 498 114.81 57,175
2015-12-18 Huizenga Theodore Alan (Controller and PAO) Sale 1,500 110.55 165,825
2015-12-18 Huizenga Theodore Alan (Controller and PAO) Option Ex 1,500 21.00 31,500
2015-12-10 Sharp Shalini (CFO & Senior Vice President) Sale 12,000 101.59 1,219,140
2015-12-10 Sharp Shalini (CFO & Senior Vice President) Option Ex 12,000 .81 9,780
2015-11-30 Kakkis Emil D (President & CEO) Sale 20,000 98.09 1,961,900
2015-11-23 Agarwal Sunil (Chief Medical Officer) Sale 498 95.88 47,748
2015-10-30 Kakkis Emil D (President & CEO) Sale 20,000 99.92 1,998,400
2015-10-20 Agarwal Sunil (Chief Medical Officer) Sale 649 85.51 55,495
2015-09-22 Agarwal Sunil (Chief Medical Officer) Sale 498 109.51 54,535
2015-08-20 Agarwal Sunil (Chief Medical Officer) Sale 17,020 110.67 1,883,654
2015-08-20 Agarwal Sunil (Chief Medical Officer) Option Ex 10,000 55.88 558,800
2015-08-12 Kassberg Thomas Richard (CBO & Senior Vice President) Sale 3,334 109.70 365,739
2015-07-20 Sharp Shalini (CFO & Senior Vice President) Sale 7,708 131.67 1,014,934
2015-07-08 Kassberg Thomas Richard (CBO & Senior Vice President) Sale 3,334 102.12 340,468
2015-06-18 Sharp Shalini (CFO & Senior Vice President) Sale 4,000 96.15 384,600
2015-06-17 Huizenga Theodore Alan (Controller and PAO) Sale 1,500 94.80 142,200
2015-06-17 Huizenga Theodore Alan (Controller and PAO) Option Ex 1,500 21.00 31,500
2015-06-10 Kassberg Thomas Richard (CBO & Senior Vice President) Sale 3,334 88.19 294,025
2015-05-18 Sharp Shalini (CFO & Senior Vice President) Sale 4,000 79.43 317,720
2015-05-13 Kassberg Thomas Richard (CBO & Senior Vice President) Sale 3,334 72.04 240,181
2015-05-01 Sharp Shalini (CFO & Senior Vice President) Option Ex 1,000 .81 815
2015-04-20 Sharp Shalini (CFO & Senior Vice President) Sale 4,000 61.87 247,460
2015-04-08 Kassberg Thomas Richard (CBO & Senior Vice President) Sale 3,333 58.02 193,380
2015-03-19 Fust Matthew K Option Ex 6,319 21.00 132,699
2015-03-18 Sharp Shalini (CFO & Senior Vice President) Sale 4,000 61.45 245,800
2015-03-11 Kassberg Thomas Richard (CBO & Senior Vice President) Sale 3,333 56.30 187,647
2015-03-03 Huizenga Theodore Alan (Controller and PAO) Option Ex 2,500 21.00 52,500
2015-02-18 Sharp Shalini (CFO & Senior Vice President) Sale 4,000 54.32 217,284
2015-02-11 Kassberg Thomas Richard (CBO & Senior Vice President) Sale 3,333 54.31 181,021
2015-01-20 Sharp Shalini (CFO & Senior Vice President) Sale 4,000 51.24 204,956
2015-01-14 Kassberg Thomas Richard (CBO & Senior Vice President) Sale 3,333 51.51 171,682
2014-12-18 Sharp Shalini (CFO & Senior Vice President) Sale 4,000 44.82 179,288
2014-12-10 Kassberg Thomas Richard (CBO & Senior Vice President) Sale 3,333 40.22 134,053
2014-12-04 Aliski William (Director) Sale 6,000 42.15 252,876
2014-11-20 Sharp Shalini (CFO & Senior Vice President) Sale 4,000 44.07 176,280
2014-11-12 Kassberg Thomas Richard (CBO & Senior Vice President) Sale 3,333 41.85 139,486
2014-10-20 Aliski William (Director) Option Ex 29,108 3.01 87,615
2014-10-20 Sharp Shalini (CFO & Senior Vice President) Sale 4,000 46.02 184,080
2014-10-08 Kassberg Thomas Richard (CBO & Senior Vice President) Sale 3,333 53.26 177,515
2014-09-18 Sharp Shalini (CFO & Senior Vice President) Sale 4,000 56.00 224,000
2014-09-10 Kassberg Thomas Richard (CBO & Senior Vice President) Sale 3,333 54.82 182,715
2014-09-03 Kassberg Thomas Richard (CBO & Senior Vice President) Sale 10,000 55.00 550,000
2014-09-02 Kassberg Thomas Richard (CBO & Senior Vice President) Sale 10,000 52.82 528,200
2014-08-18 Sharp Shalini (CFO & Senior Vice President) Sale 4,000 53.97 215,880
2014-07-14 Coulter James G Sale 488,820 37.60 18,379,632
2014-01-31 Fmr Llc (Other) Buy 175,000 21.00 3,675,000
2014-01-30 Aliski William (Director) Buy 5,000 21.00 105,000
2014-01-30 Fust Matthew K (Director) Buy 5,000 21.00 105,000
2014-01-30 Sharp Shalini (CFO & Senior Vice President) Buy 4,500 21.00 94,500
2014-01-30 Kassberg Thomas Richard (Chief Business Officer & SVP) Buy 1,500 21.00 31,500

Insider trading activities including stock purchases, stock sales, and option exercises of RARE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ultragenyx Pharmaceutical Inc. (symbol RARE, CIK number 1515673) see the Securities and Exchange Commission (SEC) website.